Medicinal Products

Darzalex

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Darzalex
Active Substance daratumumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC24
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Brošura za transfuziologe, verzija 3
Brošura za zdravstvene radnike, verzija 3
Educational materials
for patients / caregivers
Kartica za bolesnike, verzija 3

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od reaktivacije virusa hepatitisa B kod primjene lijeka Darzalex 19.06.2019 Janssen-Cilag International N.V.
Back